Clark Capital Management Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Clark Capital Management Group's RPRX Position: Q3 2026 in Review
Clark Capital Management Group reduced its Royalty Pharma (RPRX) stake by 63% in Q3 2026, selling an estimated $61.8M and leaving 615,727 shares worth $35.9M. The position accounts for 0.22% of the portfolio, ranked #126.
Clark Capital Management Group first reported a position in RPRX in Q3 2025 and has held it in 5 quarters since. The position peaked at $93.2M in Q2 2026. 705 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Clark Capital Management Group held 615,727 shares of Royalty Pharma worth $35.9M as of Q3 2026.
- Clark Capital Management Group sold 1,047,276 Royalty Pharma shares in Q3 2026, an estimated $61.8M.
- Royalty Pharma made up 0.22% of Clark Capital Management Group's portfolio in Q3 2026, its #126 holding.
- Clark Capital Management Group first reported a position in Royalty Pharma in Q3 2025 and has held it in 5 quarters since.
- Clark Capital Management Group's Royalty Pharma position peaked at $93.2M in Q2 2026.
- 705 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Clark Capital Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.